Reversible progressive supranuclear palsy-Like phenotype as an initial manifestation of HIV infection

Neurological Sciences

Volumn 33, Issue 5, 2012, Pages 1169-1171

  Jang, Wooyoung ^a   Kim, Joong Seok ^b   Ahn, Jin Young ^c   Kim, Hee Tae ^a  

^a Hanyang University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Seoul Medical Center   (South Korea)

Author keywords

Highly active antiretroviral therapy; Human immunodeficiency virus; Parkinson's disease; Progressive suparnuclear palsy

Indexed keywords

ANTIRETROVIRUS AGENT; LEVODOPA;

ABNORMAL LABORATORY RESULT; AGED; ARTICLE; BASAL GANGLION; BRAIN CORTEX ATROPHY; BRAIN STEM; CASE REPORT; CAUDATE NUCLEUS; CLINICAL FEATURE; DOPAMINERGIC ACTIVITY; EYE DISEASE; FALLING; GAIT DISORDER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOMIMIA; MALE; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATIENT REFERRAL; PROGRESSIVE SUPRANUCLEAR PALSY; PUTAMEN; SACCADIC EYE MOVEMENT; UNSTEADINESS;

AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PHENOTYPE; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84869234063     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-011-0875-y     Document Type: Article

References (15)

1. Tse W, Cersosimo MG, Gracies J-M, Morgello S, Olanow CW, Koller W (2004) Movement disorders and AIDS: A review. Parkinsonism Relat Disord 10(6):323-334 (Pubitemid 38942788)
2. Cardoso F (2002) HIV-related movement disorders: Epidemiology, pathogenesis and management. CNS Drugs 16(10):663-668 (Pubitemid 35176852)
3. Mirsattari SM, Power C, Nath A (1998) Parkinsonism with HIV infection. Mov Disord 13(4):684-689 (Pubitemid 28334103)
4. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDSSPSP international workshop. Neurology 47(1):1-9 (Pubitemid 26243849)
5. Kim HT, Shields S, Bhatia KP, Quinn N (2005) Progressive supranuclear palsy-like phenotype associated with bilateral hypoxic-ischemic striopallidal lesions. Mov Disord 20(6):755-757 (Pubitemid 41051790)
6. Tan JH, Goh BC, Tambyah PA, Wilder-Smith E (2005) Paraneoplastic progressive supranuclear palsy syndrome in a patient with B-cell lymphoma. Parkinsonism Relat Disord 11(3):187-191
7. Koutsilieri E, Sopper S, Scheller C, ter Meulen V, Riederer P (2002) Parkinsonism in HIV dementia. J Neural Transm 109(5): 767-775 (Pubitemid 34810772)
8. Wenning GK, Litvan I, Tolosa E (2011) Milestones in atypical and secondary Parkinsonisms. Mov Disord 26(6):1083-1095
9. Bhidayasiri R, Riley DE, Somers JT, Lerner AJ, Büttner-Ennever JA, Leigh RJ (2001) Pathophysiology of slow vertical saccades in progressive supranuclear palsy. Neurology 57(11):2070-2077 (Pubitemid 33126876)
10. Mwanza JC, Nyamabo LK, Tylleskär T, Plant GT (2004) Neuroophthalmological disorders in HIV infected subjects with neurological manifestations. Br J Ophthalmol 88(11):1455-1459 (Pubitemid 39424730)
11. Khanlou N, Moore DJ, Chana G, Cherner M, Lazzaretto D, Dawes S, Grant I, Masliah E, Everall IP, HNRC group (2009) Increased frequency of a-synuclein in the substantia nigra in human immunodeficiency virus infection. J Neurovirol 15(2): 131-138
12. Rosso AL, Mattos JP, Correa RB, Nicaretta DH, Novis SA (2009) Parkinsonism and AIDS: A clinical comparative study before and after HAART. Arquivos De Neuro-Psiquiatria 67(3B):827-830
13. Hersh BP, Rajendran PR, Battinelli D (2001) Parkinsonism as the presenting manifestation of HIV infection: Improvement on HAART. Neurology 56(2):278-279 (Pubitemid 32095382)
14. Kobylecki C, Silverdale MA, Varma A, Dick JP, Kellett MW (2009) HIV-associated parkinsonism with levodopa-induced dyskinesia and response to highly-active antiretroviral therapy. Mov Disord 24(16):2441-2442
15. Tisch S, Brew B (2009) Parkinsonism in HIV-infected patients on highly active antiretroviral therapy. Neurology 73(5):401-403